Chunghwa Chemical Synthesis & Biotech

Chunghwa Chemical Synthesis & Biotech (CCSB) is a leading Taiwan-based Active Pharmaceutical Ingredient (API) manufacturer and Contract Development and Manufacturing Organization (CDMO) founded in 1964. The company specializes in complex chemical synthesis and large-scale fermentation technologies, providing a diverse portfolio of APIs to the global pharmaceutical industry. CCSB is well-regarded for its expertise in immunosuppressants, cardiovascular agents, and high-potency APIs (HPAPIs). Operating US FDA-inspected facilities, the company supports clients from process development and pilot-scale production to full commercial manufacturing. Their robust technical capabilities include lipid chemistry, chiral synthesis, and advanced purification processes.